Literature DB >> 23774802

The first silicon(IV) phthalocyanine-nucleoside conjugates with high photodynamic activity.

Xiao-Min Shen1, Bi-Yuan Zheng, Xiu-Rong Huang, Lei Wang, Jian-Dong Huang.   

Abstract

A series of novel silicon(IV) phthalocyanines conjugated axially with different nucleoside moieties (uridine, 5-methyluridine, cytidine, and 5-N-cytidine derivatives) have been synthesized and evaluated for their photodynamic activities. The uridine-containing compound 1 exhibits the highest photocytotoxicity against HepG2 human hepatocarcinoma cells with an IC50 value as low as 6 nM, which can be attributed to its high cellular uptake and non-aggregated nature in the biological media. This compound shows high affinity toward the mitochondria of HepG2 cells and causes cell death mainly through apoptosis upon illumination. The result indicates that 1 is a highly promising photosensitizer for photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774802     DOI: 10.1039/c3dt50910a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

1.  The water soluble axially disubstituted silicon phthalocyanines: photophysicochemical properties and in vitro studies.

Authors:  Meltem Göksel; Zekeriya Biyiklioglu; Mahmut Durmuş
Journal:  J Biol Inorg Chem       Date:  2017-06-14       Impact factor: 3.358

2.  Experimental and theoretical investigation of water-soluble silicon(IV) phthalocyanine and its interaction with bovine serum albumin.

Authors:  Shaya Y Al-Raqa; Khaoula Khezami; Esra N Kaya; Abdulkadir Kocak; Mahmut Durmuş
Journal:  J Biol Inorg Chem       Date:  2021-02-08       Impact factor: 3.358

Review 3.  An updated overview on the development of new photosensitizers for anticancer photodynamic therapy.

Authors:  Juan Zhang; Chengshi Jiang; João Paulo Figueiró Longo; Ricardo Bentes Azevedo; Hua Zhang; Luis Alexandre Muehlmann
Journal:  Acta Pharm Sin B       Date:  2017-09-22       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.